Our on-going research and development programmes are co-ordinated within the framework of a number of collaborative works and combined efforts from a number of international universities and hospitals to engineer new generation osteoinductive and osteoconductive synthetic, absorbable scaffolds with unique internal architecture with stem cells and biogenic additives for the regeneration of bone and treatment of infection, osteomyelitis and on long term combat bone loss due to osteoporosis. .
The research and development pipeline for the company holds a number of exciting new innovations to the core technology platform, positioning the company to remain at the leading edge of bio-material development.